Clin2
NCT07357675Likely a fitNot yet recruiting

Study of EA-230 for recovery after heart bypass surgery

Coronary Artery Disease (CAD)Coronary Artery Bypass Graft Surgery(CABG)

Part of Heart & circulation clinical trials.

This trial tests a study drug called EA-230 to see if it can help people recover faster after heart bypass surgery (CABG). If you are scheduled for a planned surgery with at least 3 bypass grafts, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
300 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years old or older.
  • You are scheduled for a planned (not emergency) heart bypass surgery that needs at least 3 bypass grafts.
  • You do not have severe heart, liver, kidney, or blood problems, or a weak immune system.
  • You have not had a serious infection or taken certain medications (like chemotherapy or high-dose steroids) in the last month.
  • You are willing to use effective contraception if you or your partner could become pregnant.
  • You can give written informed consent yourself.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07118449Not yet recruiting· Phase 2
Gene therapy for heart bypass patients

This trial tests a gene therapy called XC001, given directly to the heart during bypass surgery, to help grow new blood vessels and improve blood flow to areas that cannot be fully fixed with surgery alone.

Cincinnati, Ohio
NCT06434935Enrolling by invitation· Early Phase 1
Trial of a new bypass graft for heart surgery

This trial tests a new artificial blood vessel for heart bypass surgery. If you need a bypass and meet the health requirements, you may be able to receive this experimental graft.

Asunción
NCT07192211Recruiting· Phase 2
Study of ADR-002K for Heart Failure Patients Having Bypass Surgery

This study tests an experimental drug (ADR-002K) for people with heart failure caused by blocked arteries who are about to have bypass surgery. The goal is to see if it helps the heart recover better after surgery.

Osaka, Suita
NCT07574411Not yet recruiting
E-care Protocol for Heart Bypass Surgery Recovery

This study tests a digital care program designed to help patients recover after coronary artery bypass graft surgery. The program aims to improve heart health and quality of life through monitored rehabilitation training.

NCT02820233Recruiting
Study of a heart-signal drug during bypass surgery

This study looks at a treatment that affects signals between heart cells in people with severe coronary artery disease who are scheduled for bypass surgery. The goal is to see if changing these heart-cell signals can improve heart outcomes around the time of surgery.

Portland, Maine
NCT06141525Recruiting
Remote conditioning for safer heart bypass recovery

This study tests whether a simple, non-invasive treatment called remote ischemic conditioning (using a blood pressure cuff on your arm) can help patients recover better after off-pump heart bypass surgery. The goal is to see if it reduces complications and improves heart function.

Xi'an, Shaanxi

Hear when a new Coronary Artery Bypass Graft Surgery (CABG) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.